BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Klingenberg RD, Homann N, Ludwig D. Type I intestinal lymphangiectasia treated successfully with slow-release octreotide. Dig Dis Sci. 2003;48:1506-1509. [PMID: 12924644 DOI: 10.1023/a:1024707605493] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Feng H, Zou L, Zhai X, Zhang S, Li J. Hypomagnesemia in intestinal lymphangiectasia: a case report and review of the literature. BMC Gastroenterol 2022;22. [DOI: 10.1186/s12876-022-02318-6] [Reference Citation Analysis]
2 El Haddar Z, Sbia Y, Rkain M, Benajiba N, Babakhouya A. Complicated primary intestinal lymphangiectasia (Waldmann's disease) in a child successfully treated with octreotide: A case report from a low-resource setting. Ann Med Surg (Lond) 2021;68:102588. [PMID: 34401115 DOI: 10.1016/j.amsu.2021.102588] [Reference Citation Analysis]
3 Huber R, Semmler G, Mayr A, Offner F, Datz C. Primary intestinal lymphangiectasia in an adult patient: A case report and review of literature. World J Gastroenterol 2020; 26(48): 7707-7718 [PMID: 33505146 DOI: 10.3748/wjg.v26.i48.7707] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Alshikho MJ, Talas JM, Noureldine SI, Zazou S, Addas A, Kurabi H, Nasser M. Intestinal Lymphangiectasia: Insights on Management and Literature Review. Am J Case Rep 2016;17:512-22. [PMID: 27440277 DOI: 10.12659/ajcr.899636] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
5 El-Etreby SA, Altonbary AY, Sorogy ME, Elkashef W, Mazroa JA, Bahgat MH. Anaemia in Waldmann’s disease: A rare presentation of a rare disease. World J Gastrointest Endosc 2015; 7(5): 567-572 [PMID: 25992197 DOI: 10.4253/wjge.v7.i5.567] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
6 Sinani SA, Rawahi YA, Abdoon H. Octreotide in Hennekam syndrome-associated intestinal lymphangiectasia. World J Gastroenterol 2012; 18(43): 6333-6337 [PMID: 23180957 DOI: 10.3748/wjg.v18.i43.6333] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
7 Suehiro K, Morikage N, Murakami M, Yamashita O, Hamano K. Late-onset primary intestinal lymphangiectasia successfully managed with octreotide: a case report. Ann Vasc Dis 2012;5:96-9. [PMID: 23555496 DOI: 10.3400/avd.cr.11.00085] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
8 Popović DD, Spuran M, Alempijević T, Krstić M, Djuranović S, Kovacević N, Damnjanović S, Micev M. [Congenital intestinal lymphangiectasia]. Vojnosanit Pregl 2011;68:270-3. [PMID: 21526555 DOI: 10.2298/vsp1103270p] [Reference Citation Analysis]
9 Freeman HJ, Nimmo M. Intestinal lymphangiectasia in adults. World J Gastrointest Oncol 2011; 3(2): 19-23 [PMID: 21364842 DOI: 10.4251/wjgo.v3.i2.19] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 39] [Article Influence: 4.9] [Reference Citation Analysis]
10 Wen J, Tang Q, Wu J, Wang Y, Cai W. Primary intestinal lymphangiectasia: four case reports and a review of the literature. Dig Dis Sci. 2010;55:3466-3472. [PMID: 20198428 DOI: 10.1007/s10620-010-1161-1] [Cited by in Crossref: 54] [Cited by in F6Publishing: 38] [Article Influence: 4.5] [Reference Citation Analysis]
11 Vignes S, Bellanger J. Primary intestinal lymphangiectasia (Waldmann's disease). Orphanet J Rare Dis. 2008;3:5. [PMID: 18294365 DOI: 10.1186/1750-1172-3-5] [Cited by in Crossref: 138] [Cited by in F6Publishing: 111] [Article Influence: 9.9] [Reference Citation Analysis]
12 Knight AK, Mayer L, Franks AG Jr, Cunningham-Rundles C. Hypogammaglobulinemia with facial edema. PLoS Med 2006;3:e475. [PMID: 17194183 DOI: 10.1371/journal.pmed.0030475] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]